| |
| |
|
| Insider
Information: |
Horn Howard |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
330,478 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,319,868 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
330,478 |
|
|
| Total
Value |
$4,319,868 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vir Biotechnology, Inc. |
VIR |
CFO |
2023-02-23 |
230,712 |
|
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
99,766 |
2023-10-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
19,400 |
99,766 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Chief Financial Officer |
• – – |
2023-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
80,366 |
80,336 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2023-02-23 |
4 |
S |
$25.97 |
$58,387 |
D/D |
(2,248) |
230,712 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2023-02-17 |
4 |
S |
$25.29 |
$61,298 |
D/D |
(2,424) |
232,960 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
235,384 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2022-02-17 |
4 |
S |
$31.93 |
$76,411 |
D/D |
(2,393) |
200,384 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
202,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2020-07-13 |
4 |
AS |
$50.06 |
$1,501,731 |
D/D |
(30,000) |
177,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2020-07-02 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
207,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2020-07-01 |
4 |
AS |
$37.72 |
$378,399 |
D/D |
(10,000) |
217,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2020-06-25 |
4 |
AS |
$50.00 |
$1,500,000 |
D/D |
(30,000) |
227,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2020-06-19 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
257,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFO |
• – – |
2020-06-01 |
4 |
AS |
$34.53 |
$351,038 |
D/D |
(10,000) |
267,777 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
CFOOfficer |
• – – |
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
277,777 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
